HOME >> BIOLOGY >> NEWS
16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

The 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics brings 2,000 international cancer experts together to present new data on leading-edge basic, translational and early clinical research.

News briefing:

12.30 hrs CET Wednesday 29 September:

Speakers and topics

    * Dr Monika Hegi: Trial identifies which brain cancer patients benefit from temozolomide: genetic predictive test can be carried out in any laboratory and means temozolomide can now become a targeted treatment.

    * Dr Ardeshir Ghavamzadeh: Trial results indicate arsenic should now be considered first-line treatment for one type of leukaemia

    *Dr Kim Chi: Successful results of Phase I trial of the first second generation antisense cancer drug - phase II getting under way

    * Dr Grant McArthur: Award winning researcher reveals potential new role for Glivec in a soft tissue cancer

Chairman: Professor Jaap Verweij (EORTC chairman of conference scientific committee) together with scientific committee co-chairmen Dr Janet Dancey (NCI) and Dr Eric K Rowinsky (AACR)

NB: any reports involving the topics outlined above are embargoed until the time and date of the news briefings.

Journalists wishing to dial in to the news briefing should contact Margaret Willson by Friday 25 September.

More information:

Margaret Willson
Conference Press Officer

Tel: 44-153-677-2181 (office)
44-797-385-3347 (mobile)
Email: m.willson@mwcommunications.org.uk

Conference media centre:
From 16.00 hrs CET Monday 27 September to 17.00 hrs CET Friday 1 October
Tel: 41-22-761-2205
Fax: 41-22-761-2211


'"/>

Contact: Margaret Willson
m.willson@mwcommunications.org.uk
44-015-367-72181
European Organisation for Research and Treatment of Cancer
22-Sep-2004


Page: 1

Related biology news :

1. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
2. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
3. Health of worlds sea lions the focus of Wakefield Symposium
4. Chemical signals health of brain cells Symposium
5. Final Alert: 16th EORTC NCI AACR Symposium
6. 16th EORTC NCI AACR Symposium
7. Symposium to tackle questions of genetic engineering and biodiversity
8. Fostering Diversity in the Sciences Symposium
9. Annual Chemical Biology Symposium at Yale May 14, 2004
10. Symposium relates long-term ecological research to ecosystem management
11. Symposium examines the growing influence of aerosols on climate

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
(Date:4/5/2017)... -- KEY FINDINGS The global market for ... of 25.76% during the forecast period of 2017-2025. The ... the growth of the stem cell market. ... INSIGHTS The global stem cell market is segmented on ... stem cell market of the product is segmented into ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... , ... October 11, 2017 , ... ComplianceOnline’s Medical Device ... on 7th and 8th June 2018 in San Francisco, CA. The Summit brings together ... as several distinguished CEOs, board directors and government officials from around the world to ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... implantation and pregnancy rates in frozen and fresh in vitro fertilization (IVF) ... and maternal age to IVF success. , After comparing the results from the ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO ... Diego Rotary Club. The event entitled “Stem Cells and Their Regenerative ... attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. ...
(Date:10/9/2017)... 9, 2017  BioTech Holdings announced today identification ... its ProCell stem cell therapy prevents limb loss ... Company, demonstrated that treatment with ProCell resulted in ... as compared to standard bone marrow stem cell ... in reduction of therapeutic effect.  ...
Breaking Biology Technology:
Cached News: